Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-NP in Progressive Multiple Sclerosis
NCT03355365Phase 2Completed
- Start
- Sep 2018
- Primary completion
- Feb 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cell-derived neural progenitor cells in multiple sclerosis (MS). Started Sep 2018; status: completed.
02
Drugs
mesenchymal stem cell-derived neural progenitor cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03355365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355365.